MX2010002167A - Medicamentos que contienen levaduras. - Google Patents

Medicamentos que contienen levaduras.

Info

Publication number
MX2010002167A
MX2010002167A MX2010002167A MX2010002167A MX2010002167A MX 2010002167 A MX2010002167 A MX 2010002167A MX 2010002167 A MX2010002167 A MX 2010002167A MX 2010002167 A MX2010002167 A MX 2010002167A MX 2010002167 A MX2010002167 A MX 2010002167A
Authority
MX
Mexico
Prior art keywords
pharmaceutical product
yeast
drug
releases
carbon dioxide
Prior art date
Application number
MX2010002167A
Other languages
English (en)
Inventor
Bodo Asmussen
Werner Weitschies
Christiane Schiller
Mahmoud A Omer-Adam
Stefan Nagel
Grzegorz Garbacz
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40299087&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2010002167(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of MX2010002167A publication Critical patent/MX2010002167A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención se refiere a un medicamento con dosificación controlada del principio activo contenido en el mismo, que contiene levadura apta para la fermentación, cuya producción de dióxido de carbono libera el principio activo del medicamento.
MX2010002167A 2007-09-01 2008-08-21 Medicamentos que contienen levaduras. MX2010002167A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007041588A DE102007041588A1 (de) 2007-09-01 2007-09-01 Arzneimittel mit Hefe
PCT/EP2008/006897 WO2009052888A2 (de) 2007-09-01 2008-08-21 Arzneimittel mit hefe

Publications (1)

Publication Number Publication Date
MX2010002167A true MX2010002167A (es) 2010-04-29

Family

ID=40299087

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010002167A MX2010002167A (es) 2007-09-01 2008-08-21 Medicamentos que contienen levaduras.

Country Status (14)

Country Link
US (1) US20120027856A1 (es)
EP (1) EP2180885B1 (es)
JP (1) JP2010536903A (es)
KR (1) KR101259673B1 (es)
CN (1) CN101795676B (es)
AU (1) AU2008316051A1 (es)
CA (1) CA2698327C (es)
DE (1) DE102007041588A1 (es)
ES (1) ES2456267T3 (es)
MX (1) MX2010002167A (es)
NZ (1) NZ584233A (es)
RU (1) RU2452473C2 (es)
WO (1) WO2009052888A2 (es)
ZA (1) ZA201000853B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009027938A1 (de) * 2009-07-22 2011-01-27 Universität Greifswald Orales therapeutisches System und seine Verwendung
WO2013159068A1 (en) * 2012-04-20 2013-10-24 Enmotus Inc. Storage system with data management mechanism and method of operation thereof
KR20170015315A (ko) * 2014-06-10 2017-02-08 라이온 가부시키가이샤 청주 효모를 함유하는 정제
US11291683B2 (en) 2016-04-01 2022-04-05 Access Business Group International Llc Bilayer tablets of B vitamins and process for preparing the same

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675174A (en) * 1985-08-16 1987-06-23 Alza Corporation Veterinary dispenser delivering beneficial agent by gas power generated in situ
ES2097155T3 (es) 1989-10-02 1997-04-01 Cima Labs Inc Forma de dosificacion efervescente y metodo de administracion.
ATE251449T1 (de) * 1999-06-14 2003-10-15 Cosmo Spa Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe
DE10120092B4 (de) * 2001-04-25 2008-03-20 Lts Lohmann Therapie-Systeme Ag Magensaftresistente Vorrichtung zur Freisetzung von mukoadhäsiven Wirkstoffträgern und Verfahren zur Herstellung der magensaftresistenten Vorrichtung
GB0114069D0 (en) * 2001-06-08 2001-08-01 Smithkline Beecham Plc Composition
WO2002102415A1 (en) * 2001-06-18 2002-12-27 Blue Cross Laboratories Limited Gastric floating system
WO2003000112A2 (en) 2001-06-20 2003-01-03 The Governement Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of ribonuclease l in diagnosis of cancer
DE10224607B4 (de) * 2002-06-04 2008-03-13 Lts Lohmann Therapie-Systeme Ag Filmförmige, zerfallsfähige Zubereitungen zur Wirkstofffreisetzung und Verfahren zu deren Herstellung
WO2004032906A1 (en) * 2002-10-11 2004-04-22 Depomed Development, Ltd. Gastro-retentive levodopa delivery form
US6835397B2 (en) * 2002-12-23 2004-12-28 Balchem Corporation Controlled release encapsulated bioactive substances
US20060003003A1 (en) 2004-06-28 2006-01-05 Bakker Johan A Oral sustained release formulation of tedisamil with gastric retention properties
DE102004042139B4 (de) 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
US7799328B2 (en) * 2004-12-23 2010-09-21 Biocodex Method for treating weight loss in patients suffering from inflammatory bowel diseases
AU2008273095A1 (en) * 2007-07-12 2009-01-15 Dsm Ip Assets B.V. Nitrate reduction by a probiotic in the presence of a heme

Also Published As

Publication number Publication date
ZA201000853B (en) 2010-10-27
CN101795676B (zh) 2012-11-28
WO2009052888A2 (de) 2009-04-30
CN101795676A (zh) 2010-08-04
DE102007041588A1 (de) 2009-03-05
CA2698327C (en) 2013-04-30
RU2452473C2 (ru) 2012-06-10
JP2010536903A (ja) 2010-12-02
WO2009052888A3 (de) 2009-10-15
RU2010109523A (ru) 2011-10-20
EP2180885A2 (de) 2010-05-05
KR20100059880A (ko) 2010-06-04
AU2008316051A1 (en) 2009-04-30
ES2456267T3 (es) 2014-04-21
CA2698327A1 (en) 2009-04-30
EP2180885B1 (de) 2014-01-29
KR101259673B1 (ko) 2013-05-06
NZ584233A (en) 2012-02-24
US20120027856A1 (en) 2012-02-02

Similar Documents

Publication Publication Date Title
HK1148202A1 (en) Pharmaceutical solutions, process of preparation and therapeutic uses
MX344246B (es) Procedimiento para la preparacion de cloruros de acido 5-fluoro-1-alquil-3-fluoroalquil-1h-pirazol-4-carboxilico.
MX2010007587A (es) Compuestos que comprenden un grupo ciclobutoxi.
UA104613C2 (en) Alkylamine-substituted dicyanopyridines and amino acid ester prodrugs thereof
MX2011009369A (es) 2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
WO2007106738A3 (en) Acrylated hyaluronic acid
WO2009100995A3 (de) Lagerstabile produktsysteme für prämixformulierungen
WO2010031720A3 (en) Novel antibody formulation
WO2010015657A3 (en) Alkoxypyrazoles and the process for their preparation
IN2012KN02804A (es)
WO2012031164A3 (en) Drug delivery by carbon nanotube arrays
WO2010102778A3 (de) Substituierte 3-aminoisoxazolopyridine als kcnq2/3 modulatoren
USD650833S1 (en) Typeface
WO2011009938A3 (en) Stambomycin and derivatives, their production and their use as drugs
WO2009115084A3 (de) Pyrrolopyrimidin-derivate und deren verwendungen
WO2010027150A3 (en) New preparation of hydroxychloroquine
WO2010060624A3 (de) Trockenverarbeitung und neue formen von lacosamid
MX2011008662A (es) 2-mercapto-3-aminopiridinas sustituidas como moduladores de kcnq2/3.
MX2011009338A (es) 3-amino-2-mercaptoquinolinas sustituidas como moduladores de kcnq2/3.
UA97401C2 (ru) Экструдат с улучшенной маскировкой вкуса
WO2011067236A3 (de) Raltegravir-polymorphe
WO2010079045A3 (en) Crystalline salt forms of flibanserine
IT1400139B1 (it) Un procedimento per la produzione di idrogeno, per il sequestro di anidride carbonica e per la produzione di materiali da costruzione a partire da scorie e/o ceneri industriali.
MX2010002167A (es) Medicamentos que contienen levaduras.
MX2012006834A (es) Sintesis controlada de acido poliglutamico.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal